Delcath kündigt anlässlich des European Multidisciplinary Cancer Congress...
New York und Stockholm (ots/PRNewswire) - – Daten vom März 2011 bestätigen Wirksamkeit mit Behandlung durch Chemosättigung Delcath Systems hat heute bekannt gegeben, dass James F. Pingpank, MD, FACS...
View ArticlePositive Phase 2 Clinical Data With Tivantinib in Hepatocellular Carcinoma to...
Woburn, Massachusetts And Tokyo (ots/PRNewswire) – ArQule, Inc. and Daiichi Sankyo, Co., Ltd. (TSE 4568) today announced that an oral presentation at the Annual Meeting of the American Society of...
View ArticleJanssen Submits Additional Marketing Applications for ZYTIGA® in the European...
Beerse, Belgium And Raritan, New Jersey (ots/PRNewswire) – ? Simultaneous Submissions Based on Data from Pre-chemo Prostate Cancer Study Janssen-Cilag International NV announced today it has submitted...
View ArticleSix-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily...
Paris (ots/PRNewswire) – Results Presented at 17th Congress of the European Hematology Association Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up...
View ArticleThree-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once-Daily...
Paris (ots/PRNewswire) – Results Presented at 17th Congress of the European Hematology Association Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced results from the...
View ArticleEisai Announces Preliminary Results of Phase III Study of Halaven® (Eribulin)...
Hatfield, England (ots/PRNewswire) – Eisai Europe Limited today announces preliminary results from a recently completed Phase III study (Study 301) comparing Halaven(R) (eribulin) and Xeloda(R)...
View ArticleEANS-News: AGENNIX AG gibt weitere Daten zu Talactoferrin alfa bekannt
——————————————————————————– Corporate News übermittelt durch euro adhoc. Für den Inhalt ist der Emittent/Meldungsgeber verantwortlich. ——————————————————————————– Forschung/Entwicklung Planegg/München...
View ArticleEANS-News: AGENNIX AG Reports Additional Talactoferrin Alfa Data
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Research &...
View ArticleRecord Number of Bendamustine Abstracts Accepted for Presentation at the...
Cambridge, England (ots/PRNewswire) - – Total of 43 bendamustine abstracts to be presented at ASH, including five oral presentations – New data supports use of bendamustine-rituximab (B-R) regimen in...
View ArticleCellSearch® ‘Liquid Biopsy’ Approved for Breast Cancer Patients in China
Raritan, New Jersey (ots/PRNewswire) – Veridex, LLC today announced approval from the China State Food & Drug Administration (SFDA) for the CellSearch(R) circulating tumor cell (CTC) test as an in...
View ArticlePhase 3 Data Published in The Lancet Show Bendamustine (Levact®) Plus...
Cambridge, England (ots/PRNewswire) – NOT INTENDED FOR MEDIA IN THE NETHERLANDS -Treatment with bendamustine plus rituximab (B-R) doubles progression free survival (PFS) compared with current standard...
View ArticleDGAP-News: WILEX AG publishes 3-months financial report 2013
DGAP-News: WILEX AG / Key word(s): Interim Report WILEX AG publishes 3-months financial report 2013 11.04.2013 / 07:07 ——————————————————————— PRESS RELEASE WILEX publishes 3-months financial report...
View Article
